Search results for " REGENERATIVE MEDICINE"

showing 10 items of 67 documents

Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies

2015

In recent years, mesenchymal stromal cells (MSCs) have been largely investigated and tested as a new therapeutic tool for several clinical applications, including the treatment of different rheumatic diseases. MSCs are responsible for the normal turnover and maintenance of adult mesenchymal tissues as the result of their multipotent differentiation abilities and their secretion of a variety of cytokines and growth factors. Although initially derived from bone marrow, MSCs are present in many different tissues such as many peri-articular tissues. MSCs may exert immune-modulatory properties, modulating different immune cells in both in vitro and in vivo models, and they are considered immune-…

AdultCancer ResearchpathogenesiCellular differentiationImmunologyCell- and Tissue-Based TherapyBone Marrow CellsMesenchymal Stem Cell TransplantationRegenerative MedicineRegenerative medicineAutoimmune DiseaseAutoimmune DiseasesChondrocytesImmune systemIn vivoBone MarrowRheumatic DiseasesmedicineHumansImmunology and Allergyrheumatic diseaseGenetics (clinical)TransplantationOsteoblastsMesenchymal Stromal Cellbusiness.industryOsteoblastMesenchymal stem cellMesenchymal Stem CellsCell DifferentiationCell BiologyChondrocyteClinical trialmedicine.anatomical_structureregenerative therapyOncologymesenchymal stromal cells; pathogenesis; regenerative therapy; rheumatic disease; Adult; Autoimmune Diseases; Bone Marrow; Bone Marrow Cells; Cell Differentiation; Cell- and Tissue-Based Therapy; Chondrocytes; Humans; Mesenchymal Stem Cell Transplantation; Mesenchymal Stromal Cells; Osteoblasts; Regenerative Medicine; Rheumatic DiseasesImmunologyBone Marrow CellBone marrowStem cellbusinessHuman
researchProduct

Prognosis after surgery for multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: Functionality matters

2021

Contains fulltext : 245221.pdf (Publisher’s version ) (Open Access) BACKGROUND: Metastasized pancreatic neuroendocrine tumors are the leading cause of death in patients with multiple endocrine neoplasia type 1. Aside from tumor size, prognostic factors of pancreatic neuroendocrine tumors are largely unknown. The present study aimed to assess whether the prognosis of patients with resected multiple endocrine neoplasia type 1-related nonfunctioning pancreatic neuroendocrine tumors differs from those with resected multiple endocrine neoplasia type 1-related insulinomas and assessed factors associated with prognosis. METHODS: Patients who underwent resection of a multiple endocrine neoplasia ty…

AdultDiagnostic ImagingMalemedicine.medical_specialtyAdolescentBiopsy030230 surgeryNeuroendocrine tumorsGastroenterologyArticleYoung Adult03 medical and health sciences0302 clinical medicineInternal medicineBiopsyTumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14]Multiple Endocrine Neoplasia Type 1medicineHumansMEN1Neoplasm MetastasisChildMultiple endocrine neoplasiaLymph nodeInsulinomaAgedNeoplasm StagingCause of deathAged 80 and overmedicine.diagnostic_testbusiness.industryLiver NeoplasmsHazard ratioDisease ManagementMiddle AgedPrognosismedicine.diseaseReconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10]Pancreatic NeoplasmsPatient Outcome AssessmentNeuroendocrine Tumorsmedicine.anatomical_structure030220 oncology & carcinogenesisFemaleSurgeryDisease SusceptibilityNeoplasm GradingbusinessBiomarkers
researchProduct

Association study of a SNP coding for a M129V substitution in the prion protein in schizophrenia.

2003

AdultPsychosisAmyloidAdolescentGenotypePrionsSchizophrenia (object-oriented programming)610 Medicine & healthBiologymedicine.disease_causeGenetic determinismPrion Proteins2738 Psychiatry and Mental HealthOpen Reading FramesPolymorphism (computer science)medicineSNPHumansPoint MutationGenetic Predisposition to DiseaseProtein PrecursorsCodonBiological PsychiatryAgedGeneticsMutationSubstitution (logic)Case-control study11359 Institute for Regenerative Medicine (IREM)Middle Agedmedicine.diseasePsychiatry and Mental healthAmino Acid SubstitutionCase-Control StudiesSchizophrenia2803 Biological PsychiatrySchizophrenia research
researchProduct

The erythropoietin and regenerative medicine: a lesson from fish

2009

Background Erythropoietin (EPO), the main haematopoietic growth factor for the proliferation and differentiation of erythroid progenitor cells, is also known for its angiogenic and regenerative properties. Materials and methods In this study, we aimed to test the regenerative effects of EPO administration in an experimental model of Sea bass (Dicentrarchus labrax) subjected to amputation of the caudal fin. Results Erythropoietin-treated fishes (3000 UI of human recombinant EPO-alpha immediately after cutting and after 15 days) showed an increased growth rate of their fins compared with those untreated (ANOVA variance: P :0 AE01 vs. P :0 AE04). By analysing fin length at established times (1…

Angiogenesismedicine.medical_treatmentClinical BiochemistryNeovascularization PhysiologicRegenerative MedicineModels BiologicalBiochemistryAndrologyangiogenesisfin growthFibrosismedicineAnimalsSea bassbiologySettore MED/27 - NeurochirurgiaMedicine (all)Growth factorFishesGeneral MedicineSea bamedicine.diseasebiology.organism_classificationImmunohistochemistryEPO regenerative medicineangiogenesis; Erythropoietin; tissue regeneration; fishAngiogenesiHaematopoiesisErythropoietinregenerationImmunologyBassDicentrarchuserythropoietinStem cellsea bassmedicine.drugEuropean Journal of Clinical Investigation
researchProduct

The Sixth Annual Translational Stem Cell Research Conference of the New York Stem Cell Foundation

2012

The New York Stem Cell Foundation's "Sixth Annual Translational Stem Cell Research Conference" convened on October 11-12, 2011 at the Rockefeller University in New York City. Over 450 scientists, patient advocates, and stem cell research supporters from 14 countries registered for the conference. In addition to poster and platform presentations, the conference featured panels entitled "Road to the Clinic" and "The Future of Regenerative Medicine". © 2012 New York Academy of Sciences.

Biochemistry Genetics and Molecular Biology (all)Muscular DiseaseDiabetes MellituHematopoietic Stem CellRegenerative MedicineStem Cell ResearchHeart DiseaseHistory and Philosophy of ScienceDiabetes Mellitus; Heart Diseases; Hematopoietic Stem Cells; Humans; Muscular Diseases; Neoplasms; Nervous System Diseases; Regenerative Medicine; Translational Medical Research; Stem Cell Research; Stem Cell Transplantation; Biochemistry Genetics and Molecular Biology (all); History and Philosophy of ScienceNeoplasmNervous System DiseaseTranslational Medical ResearchHumanStem Cell Transplantation
researchProduct

On the Interaction between 1D Materials and Living Cells

2020

One-dimensional (1D) materials allow for cutting-edge applications in biology, such as single-cell bioelectronics investigations, stimulation of the cellular membrane or the cytosol, cellular capture, tissue regeneration, antibacterial action, traction force investigation, and cellular lysis among others. The extraordinary development of this research field in the last ten years has been promoted by the possibility to engineer new classes of biointerfaces that integrate 1D materials as tools to trigger reconfigurable stimuli/probes at the sub-cellular resolution, mimicking the in vivo protein fibres organization of the extracellular matrix. After a brief overview of the theoretical models r…

Cellular membraneMaterials sciencelcsh:BiotechnologyBiomedical EngineeringTheoretical modelsregenerative medicineNanotechnologyBiointerface02 engineering and technologyReviewbioelectronics010402 general chemistry01 natural sciencesRegenerative medicineBiomaterials1D materialsbiointerfacelcsh:TP248.13-248.651D materials CNTs bioelectronics biointerface photocatalysis polymers regenerative medicineMicroscale chemistrypolymerslcsh:R5-920BioelectronicsCNTs021001 nanoscience & nanotechnology0104 chemical sciencesProtein fibreslcsh:Medicine (General)0210 nano-technologyphotocatalysisMaterial chemistryJournal of Functional Biomaterials
researchProduct

Risk factors for residual disease at re-TUR in a large cohort of T1G3 patients

2021

Item does not contain fulltext Introduction and objectives: The goals of transurethral resection of a bladder tumor (TUR) are to completely resect the lesions and to make a correct diagnosis in order to adequately stage the patient. It is well known that the presence of detrusor muscle in the specimen is a prerequisite to minimize the risk of under staging. Persistent disease after resection of bladder tumors is not uncommon and is the reason why the European Guidelines recommended a re-TUR for all T1 tumors. It was recently published that when there is muscle in the specimen, re-TUR does not influence progression or cancer specific survival. We present here the patient and tumor factors th…

Detrusor musclemedicine.medical_specialty030232 urology & nephrologyUrologyDiseaseLogistic regression03 medical and health sciencesTumor Status0302 clinical medicineRe-transurethral resection of the bladderRecurrenceRisk FactorsUrological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15]MedicineHumansStage (cooking)Non-muscle invasive bladder cancer; Re-transurethral resection of the bladder; Residual disease; Recurrence; ProgressionNeoplasm StagingRetrospective StudiesUnivariate analysisCarcinoma Transitional CellProgressionbusiness.industryRetrospective cohort studyGeneral MedicineResidual diseaseReconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10]Settore MED/24medicine.anatomical_structureUrinary Bladder NeoplasmsConcomitantNon-muscle invasive bladder cancerbusiness
researchProduct

Mesenchymal stem cells derived from inflamed gingival tissue for in vivo bone tissue engineering: preliminary results.

2017

GMSCPLLATissue engineering regenerative medicine stem cells human inflamed gingival tissue bone.
researchProduct

Association of Gestational Weight Gain With Adverse Maternal and Infant Outcomes

2019

Importance: Both low and high gestational weight gain have been associated with adverse maternal and infant outcomes, but optimal gestational weight gain remains uncertain and not well defined for all prepregnancy weight ranges. Objectives: To examine the association of ranges of gestational weight gain with risk of adverse maternal and infant outcomes and estimate optimal gestational weight gain ranges across prepregnancy body mass index categories. Design, setting, and participants: Individual participant-level meta-analysis using data from 196 670 participants within 25 cohort studies from Europe and North America (main study sample). Optimal gestational weight gain ranges were estimated…

Gestational hypertensionNutrition and Disease01 natural sciencesBody Mass Index0302 clinical medicinePregnancyVoeding en ZiekteMedicineBirth Weight030212 general & internal medicineObstetricsDiabetesPregnancy OutcomeGestational ageGeneral MedicineCesarean Section/statistics & numerical dataAdult; Birth Weight; Cesarean Section; Diabetes Gestational; Female; Humans; Hypertension Pregnancy-Induced; Infant Newborn; Obesity; Pregnancy; Premature Birth; Body Mass Index; Gestational Weight Gain; Pregnancy Complications; Pregnancy OutcomeGestational Weight GainGestational diabetesPremature birthGestationalHypertensionPremature BirthFemalemedicine.symptomUnderweightPREGNANT-WOMENAdultmedicine.medical_specialtyBirth weightPregnancy-InducedHealthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18]03 medical and health sciencesAll institutes and research themes of the Radboud University Medical CenterLife ScienceHumansObesity0101 mathematicsbusiness.industryCesarean Section010102 general mathematicsInfant NewbornInfantHypertension Pregnancy-Inducedmedicine.diseaseNewbornReconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10]BODY-MASS INDEXPregnancy ComplicationsDiabetes GestationalbusinessBody mass indexWeight gain
researchProduct

Impact of maternal body mass index and gestational weight gain on pregnancy complications: an individual participant data meta-analysis of European, …

2019

ObjectiveTo assess the separate and combined associations of maternal pre‐pregnancy body mass index (BMI) and gestational weight gain with the risks of pregnancy complications and their population impact.DesignIndividual participant data meta‐analysis of 39 cohorts.SettingEurope, North America, and Oceania.Population265 270 births.MethodsInformation on maternal pre‐pregnancy BMI, gestational weight gain, and pregnancy complications was obtained. Multilevel binary logistic regression models were used.Main outcome measuresGestational hypertension, pre‐eclampsia, gestational diabetes, preterm birth, small and large for gestational age at birth.ResultsHigher maternal pre‐pregnancy BMI and gesta…

Gestational hypertensionand promotion of well-beingNutrition and DiseaseBirthweightReproductive health and childbirthLow Birth Weight and Health of the NewbornCardiovascularMedical and Health SciencesDISEASECohort Studies0302 clinical medicine3123 Gynaecology and paediatricsRisk FactorsPregnancyVoeding en ZiekteInfant MortalityOdds RatioMedicineBirth Weight2.1 Biological and endogenous factorsEPIDEMIOLOGYwq_200Aetiology2. Zero hungerPediatricRISKeducation.field_of_studyOUTCOMES030219 obstetrics & reproductive medicineObstetricspregnancy complicationsDiabetesObstetrics and GynecologyGestational ageweight gainASSOCIATIONGestational Weight GainGestational diabetesEuropeBirthweight ; Body Mass Index ; Pregnancy Complications ; Preterm Birth ; Weight GainOBESITYFemalemedicine.symptomAdultmedicine.medical_specialtyPRETERM BIRTHBirth weightPopulationGestational Agebody mass index[SDV.MHEP.GEO]Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetricswa_310Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18]03 medical and health sciencesAll institutes and research themes of the Radboud University Medical CenterPretermClinical ResearchHumanswq_100ObesityeducationObstetrics & Reproductive MedicineMetabolic and endocrineNutritionPregnancybusiness.industryContraception/ReproductionPreventionBirthweight; body mass index; pregnancy complications; preterm birth; weight gainAustraliaInfantbirth weightpreterm birthDIABETES-MELLITUSPreterm birth weight gainOverweightPerinatal Period - Conditions Originating in Perinatal Periodmedicine.diseaseNewbornPrevention of disease and conditionsReconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10]Good Health and Well BeingNorth America3.1 Primary prevention interventions to modify behaviours or promote wellbeingpregnancy complicationbusinessWeight gainBody mass indexwb_200
researchProduct